# Dichloroacetate (DCA) for the Treatment of Pulmonary Arterial Hypertension

> **NCT01083524** · PHASE1 · COMPLETED · sponsor: **University of Alberta** · enrollment: 30 (actual)

## Conditions studied

- Pulmonary Hypertension (Idiopathic, Familial or Anorexigen-associated)

## Interventions

- **DRUG:** Dichloroacetate Sodium
- **DRUG:** Dichloroacetate Sodium
- **DRUG:** Dichloroacetate Sodium

## Key facts

- **NCT ID:** NCT01083524
- **Lead sponsor:** University of Alberta
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2013-09
- **Final completion:** 2013-09
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2014-06-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01083524

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01083524, "Dichloroacetate (DCA) for the Treatment of Pulmonary Arterial Hypertension". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01083524. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*